Wiley Bros.-aintree Capital »

Cabaletta Bio shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $50k 16k 3.11

More positions owned by Wiley Bros.-aintree Capital

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Micron Technology (MU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Cabaletta Bio

Jennison Associates
Bain Capital Life Sciences Investors
BlackRock
Adage Capital Partners GP
Vanguard Capital Management
Cormorant Asset Management
Woodline Partners
Citadel Advisors
Norges Bank Investment Management
Opaleye Management
Geode Capital Management
Susquehanna International
Franklin Resources
Goldman Sachs Group
Millennium Management

View all funds holding Cabaletta Bio